InvestorsHub Logo
Followers 10
Posts 1244
Boards Moderated 0
Alias Born 10/12/2012

Re: None

Saturday, 10/19/2013 8:33:50 PM

Saturday, October 19, 2013 8:33:50 PM

Post# of 30990
"NF-kappaB inhibition combined with HO-1 inhibition potentially provides a novel therapeutic approach to treat chemotherapy-resistant forms of AML."

Article at: http://www.ncbi.nlm.nih.gov/pubmed/20332229
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.